Global Quality Statements on Reliever Use in Asthma in Adults and Children Older than 5 Years of Age

INTRODUCTION: Widespread misuse of short-acting beta-agonists (SABAs) may contribute to asthma-related morbidity and mortality. Recognizing this, the Global Initiative for Asthma neither recommends SABA monotherapy nor regards this formulation as a preferred reliever. Many health systems and healthc...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaplan, Alan G., Correia-de-Sousa, Jaime, McIvor, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882466/
https://www.ncbi.nlm.nih.gov/pubmed/33586006
http://dx.doi.org/10.1007/s12325-021-01621-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882466/
https://www.ncbi.nlm.nih.gov/pubmed/33586006
http://dx.doi.org/10.1007/s12325-021-01621-0

Ejemplares similares